• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清对氧磷酶1活性水平低预示冠状动脉疾病的严重程度。

Low serum paraoxonase1 activity levels predict coronary artery disease severity.

作者信息

Sun Ting, Hu Jingchao, Yin Zhaofang, Xu Zuojun, Zhang Liang, Fan Li, Zhuo Yang, Wang Changqian

机构信息

Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200025, China.

出版信息

Oncotarget. 2017 Mar 21;8(12):19443-19454. doi: 10.18632/oncotarget.14305.

DOI:10.18632/oncotarget.14305
PMID:28038449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5386696/
Abstract

Paraoxonase1 (PON1) activity is closely related to coronary artery disease (CAD). However, whether PON1 activity can predict the degree of coronary stenosis remains unknown. In the present study, the serum PON1 activity and related factors that influence PON1 activity were analyzed in 186 patients with diagnostic coronary angiography. The serum PON1 activity was determined using a spectrophotometry-based assay in 186 patients with diagnostic coronary angiography, in which coronary stenosis severity was graded and clinically defined as single- or multi-vessel stenosis >50%. Target lesion stenosis was quantified via quantitative coronary angiography (QCA). The serum PON1 activity was significantly decreased in the CAD group, the multiple coronary stenosis subgroup, and the diabetes mellitus subgroup compared with each control group. The PON1 activity was positively correlated with the High density lipoprotein cholesterol (HDL-C) and Apolipoprotein A1 (ApoA1). Males, smoking, diabetes, and heart failure were identified as factors that influenced PON1 activity. Furthermore, a Receiver Operating Characteristic Curve (ROC) analysis indicated that a PON1 activity cut-off point of 330 U/L could predict CAD with a sensitivity of 52% and a specificity of 65%. In conclusion, low PON1 activity predicted the degree of coronary lesion, particularly in multiple vessel lesions, smokers, and diabetes, which may represent a biochemical marker for the severity of CAD.

摘要

对氧磷酶1(PON1)活性与冠状动脉疾病(CAD)密切相关。然而,PON1活性是否能够预测冠状动脉狭窄程度仍不清楚。在本研究中,对186例接受诊断性冠状动脉造影的患者的血清PON1活性及影响PON1活性的相关因素进行了分析。采用基于分光光度法的检测方法测定了186例接受诊断性冠状动脉造影患者的血清PON1活性,其中冠状动脉狭窄严重程度进行了分级,临床上定义为单支或多支血管狭窄>50%。通过定量冠状动脉造影(QCA)对目标病变狭窄进行量化。与各对照组相比,CAD组、多支冠状动脉狭窄亚组和糖尿病亚组的血清PON1活性显著降低。PON1活性与高密度脂蛋白胆固醇(HDL-C)和载脂蛋白A1(ApoA1)呈正相关。男性、吸烟、糖尿病和心力衰竭被确定为影响PON1活性的因素。此外,受试者工作特征曲线(ROC)分析表明,PON1活性截断点为330 U/L时可预测CAD,灵敏度为52%,特异性为65%。总之,低PON1活性可预测冠状动脉病变程度,尤其是在多支血管病变、吸烟者和糖尿病患者中,这可能代表了CAD严重程度的一种生化标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8138/5386696/919f4342d840/oncotarget-08-19443-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8138/5386696/293950ca1725/oncotarget-08-19443-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8138/5386696/919f4342d840/oncotarget-08-19443-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8138/5386696/293950ca1725/oncotarget-08-19443-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8138/5386696/919f4342d840/oncotarget-08-19443-g002.jpg

相似文献

1
Low serum paraoxonase1 activity levels predict coronary artery disease severity.血清对氧磷酶1活性水平低预示冠状动脉疾病的严重程度。
Oncotarget. 2017 Mar 21;8(12):19443-19454. doi: 10.18632/oncotarget.14305.
2
Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.2型糖尿病患者中载脂蛋白A-I糖基化升高与高密度脂蛋白相关对氧磷酶1、3活性降低的关联及其与冠状动脉疾病血管造影严重程度的相互作用。
Cardiovasc Diabetol. 2015 May 13;14:52. doi: 10.1186/s12933-015-0221-4.
3
Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.低对氧磷酶1芳基酯酶活性和高血管性血友病因子水平与非糖尿病稳定型冠心病患者的严重冠状动脉粥样硬化相关。
Med Sci Monit. 2014 Nov 25;20:2421-9. doi: 10.12659/MSM.890911.
4
Improved risk assessment of coronary artery disease by substituting paraoxonase 1 activity for HDL-C: Novel cardiometabolic biomarkers based on HDL functionality.通过替代载脂蛋白 1 活性来评估冠心病风险:基于高密度脂蛋白功能的新型代谢相关心血管生物标志物。
Nutr Metab Cardiovasc Dis. 2021 Apr 9;31(4):1166-1176. doi: 10.1016/j.numecd.2020.12.026. Epub 2021 Jan 1.
5
Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.血清髓过氧化物酶/对氧磷酶1比值作为冠状动脉疾病中功能失调的高密度脂蛋白和风险分层的潜在指标。
Atherosclerosis. 2014 Jun;234(2):288-94. doi: 10.1016/j.atherosclerosis.2014.03.009. Epub 2014 Mar 19.
6
The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role?载脂蛋白酶 1(PON1)和髓过氧化物酶(MPO)作为两种与高密度脂蛋白相关的重要酶在冠心病中的联合效用:哪一种具有更强的预测作用?
Atherosclerosis. 2019 Jan;280:7-13. doi: 10.1016/j.atherosclerosis.2018.11.004. Epub 2018 Nov 8.
7
High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.高密度脂蛋白胆固醇流出能力作为动脉粥样硬化性冠心病的相关预测指标。
Atherosclerosis. 2015 Sep;242(1):318-22. doi: 10.1016/j.atherosclerosis.2015.06.028. Epub 2015 Jul 13.
8
Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease.对氧磷酶-1活性和浓度与冠状动脉疾病血管造影严重程度及范围的关联
J Am Coll Cardiol. 2006 Jun 20;47(12):2429-35. doi: 10.1016/j.jacc.2006.01.074. Epub 2006 May 26.
9
Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.印度西北部患有冠状动脉疾病和2型糖尿病的旁遮普人的对氧磷酶(PON1)活性
Indian J Med Res. 2007 Jun;125(6):783-7.
10
The relationships between PON1 activity as well as oxLDL levels and coronary artery lesions in CHD patients with diabetes mellitus or impaired fasting glucose.糖尿病或空腹血糖受损的冠心病患者中,对氧磷酶1(PON1)活性、氧化型低密度脂蛋白(oxLDL)水平与冠状动脉病变之间的关系。
Coron Artery Dis. 2008 Dec;19(8):565-73. doi: 10.1097/MCA.0b013e3283109206.

引用本文的文献

1
Correlation of the lipid complex marker hs-CRP/HDL-C ratio with hyperuricaemia: a cross-sectional retrospective study from NHANES 2015-2018.脂质复合物标志物hs-CRP/HDL-C比值与高尿酸血症的相关性:一项基于2015 - 2018年美国国家健康与营养检查调查(NHANES)的横断面回顾性研究。
Sci Rep. 2025 Mar 12;15(1):8495. doi: 10.1038/s41598-024-83126-8.
2
PON1 and PON3 in Alzheimer's Disease: Similar Functions but Different Roles.阿尔茨海默病中的对氧磷酶1和对氧磷酶3:功能相似但作用不同。
Antioxidants (Basel). 2024 Oct 10;13(10):1216. doi: 10.3390/antiox13101216.
3
High-Density Lipoprotein-Associated Paraoxonase-1 (PON-1) and Scavenger Receptor Class B Type 1 (SRB-1) in Coronary Artery Disease: Correlation with Disease Severity.

本文引用的文献

1
Study on paraoxonase 1 in type 2 diabetes mellitus.2型糖尿病中对氧磷酶1的研究。
Indian J Physiol Pharmacol. 2014 Jan-Mar;58(1):13-6.
2
Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease.小而高密度脂蛋白与稳定型冠状动脉疾病中的单核细胞亚群相关。
Atherosclerosis. 2014 Dec;237(2):589-96. doi: 10.1016/j.atherosclerosis.2014.10.015. Epub 2014 Oct 18.
3
HDL cholesterol efflux capacity and incident cardiovascular events.高密度脂蛋白胆固醇流出能力与心血管事件的发生
冠状动脉疾病中高密度脂蛋白相关对氧磷酶-1(PON-1)和B类1型清道夫受体(SRB-1):与疾病严重程度的相关性
J Clin Med. 2024 Sep 15;13(18):5480. doi: 10.3390/jcm13185480.
4
The importance of paraoxonase 1 activity in chronic kidney disease.对慢性肾脏病患者血清对氧磷酶 1 活性的重视。
Ren Fail. 2024 Dec;46(2):2376930. doi: 10.1080/0886022X.2024.2376930. Epub 2024 Jul 10.
5
Low Levels of IgM Recognizing 4-Hydroxy-2-Nonenal-Modified Apolipoprotein A-I Peptide and Its Association with the Severity of Coronary Artery Disease in Taiwanese Patients.台湾患者中识别4-羟基-2-壬烯醛修饰载脂蛋白A-I肽的低水平IgM及其与冠状动脉疾病严重程度的关联。
Curr Issues Mol Biol. 2024 Jun 20;46(6):6267-6283. doi: 10.3390/cimb46060374.
6
The predictive value of the hs-CRP/HDL-C ratio, an inflammation-lipid composite marker, for cardiovascular disease in middle-aged and elderly people: evidence from a large national cohort study.hs-CRP/HDL-C 比值作为炎症-脂质复合标志物对中老年人心血管疾病的预测价值:来自大型全国队列研究的证据。
Lipids Health Dis. 2024 Mar 1;23(1):66. doi: 10.1186/s12944-024-02055-7.
7
Relationship between the neutrophil to high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with stable coronary artery disease.稳定型冠心病患者中性粒细胞与高密度脂蛋白胆固醇比值与冠状动脉疾病严重程度的关系
Front Cardiovasc Med. 2022 Nov 24;9:1015398. doi: 10.3389/fcvm.2022.1015398. eCollection 2022.
8
Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis.对冠心病患者的对氧磷酶-1(PON-1)芳基酯酶活性水平的荟萃分析。
Dis Markers. 2022 Mar 10;2022:4264314. doi: 10.1155/2022/4264314. eCollection 2022.
9
Relationship between neutrophils to HDL-C ratio and severity of coronary stenosis.中性粒细胞与高密度脂蛋白胆固醇比值与冠状动脉狭窄严重程度的关系。
BMC Cardiovasc Disord. 2021 Mar 6;21(1):127. doi: 10.1186/s12872-020-01771-z.
10
PON1 concentration and high-density lipoprotein characteristics as cardiovascular biomarkers.PON1浓度和高密度脂蛋白特征作为心血管生物标志物。
Arch Med Sci Atheroscler Dis. 2019 Apr 12;4:e47-e54. doi: 10.5114/amsad.2019.84447. eCollection 2019.
N Engl J Med. 2014 Dec 18;371(25):2383-93. doi: 10.1056/NEJMoa1409065. Epub 2014 Nov 18.
4
Homocysteine, Paraoxonase-1 and Vascular Endothelial Dysfunction: Omnibus viis Romam Pervenitur.同型半胱氨酸、对氧磷酶-1与血管内皮功能障碍:条条大路通罗马
J Clin Diagn Res. 2014 Sep;8(9):CE01-4. doi: 10.7860/JCDR/2014/7827.4773. Epub 2014 Sep 20.
5
High-density lipoprotein subfractions and carotid plaque: the Northern Manhattan Study.高密度脂蛋白亚组分与颈动脉斑块:北曼哈顿研究
Atherosclerosis. 2014 Nov;237(1):163-8. doi: 10.1016/j.atherosclerosis.2014.09.002. Epub 2014 Sep 9.
6
Adding multiple risk factors improves Framingham coronary heart disease risk scores.增加多个风险因素可提高弗雷明汉姆冠心病风险评分。
Vasc Health Risk Manag. 2014 Sep 5;10:557-62. doi: 10.2147/VHRM.S69672. eCollection 2014.
7
Systemic inflammation, intestine, and paraoxonase-1.全身炎症、肠道与对氧磷酶-1
Adv Exp Med Biol. 2014;824:83-8. doi: 10.1007/978-3-319-07320-0_8.
8
New risk markers for cardiovascular prevention.心血管疾病预防的新风险标志物。
Curr Atheroscler Rep. 2014 Aug;16(8):427. doi: 10.1007/s11883-014-0427-z.
9
Should low high-density lipoprotein cholesterol (HDL-C) be treated?是否应该治疗低高密度脂蛋白胆固醇(HDL-C)?
Best Pract Res Clin Endocrinol Metab. 2014 Jun;28(3):353-68. doi: 10.1016/j.beem.2013.11.002. Epub 2013 Nov 15.
10
Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.血清髓过氧化物酶/对氧磷酶1比值作为冠状动脉疾病中功能失调的高密度脂蛋白和风险分层的潜在指标。
Atherosclerosis. 2014 Jun;234(2):288-94. doi: 10.1016/j.atherosclerosis.2014.03.009. Epub 2014 Mar 19.